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ABSTRACT
Herbal medicine is usually made using dry powdered herbs in the form of capsule. Capsule form herbal supplement 
suffers lower shelf life as compared to compact herbal powder in tablet form. In this study, Diabecine™, a blend of herbal 
medicine traditionally used as herbal supplement for diabetic patients was selected and transformed into a compressed 
tablet. Direct compression method and minimal usage of excipients were the aims of this study. By using direct compression, 
the blend of 40% fine powder herbs and 60% of excipients performed the best and fulfill the pharmaceutical standard. 
The safety data of microbial and heavy metal testing obtained met the safety requirements for herbal supplement category 
under the National Pharmaceutical Control Bureau of Malaysia. In conclusion, the tablet formulation of DiabecineTM is 
suitable to be manufactured by using direct compression method. This research implicates the possibility of producing 
tablets with high dose of herbal powder by direct compression method.
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ABSTRAK
Ubat herba biasanya diperbuat daripada serbuk kering herba dalam bentuk kapsul. Suplemen herba dalam bentuk kapsul 
mempunyai jangka hayat yang lebih rendah berbanding dengan serbuk herba yang dipadat dalam bentuk tablet. Dalam 
kajian ini, Diabecine™, satu campuran ubat herba yang digunakan secara tradisi sebagai suplemen herba untuk pesakit 
kencing manis telah dipilih dan diubah menjadi mampatan tablet. Kaedah pemampatan terus dan penggunaan eksipien 
yang minimum adalah matlamat kajian ini. Dengan menggunakan pemampatan terus, campuran mencapai prestasi yang 
terbaik dan memenuhi piawaian farmaseutikal. Data keselamatan ujian mikrob dan logam berat yang diperoleh telah 
memenuhi keperluan keselamatan bagi kategori suplemen herba di bawah Biro Pengawalan Farmaseutikal Kebangsaan 
Malaysia. Kesimpulannya, formulasi tablet DiabecineTM adalah sesuai untuk dimampatkan dengan menggunakan kaedah 
pemampatan terus. Kajian ini mengimplikasikan kemungkinan untuk menghasilkan tablet dengan dos serbuk herba yang 
tinggi dengan kaedah pemampatan terus. 
Kata kunci: Cemaran; ciri tablet; FTIR; pemampatan terus; suplemen herba
INTRODUCTION
Herbal plants based traditional medicine systems had 
been existed for thousands years (Cragg & Newman 
2005). Although the traditional herbal medicines widely 
trusted due to their efficacy but the products are often 
being criticized due to lack of standardization and poor 
presentation (Gbenga & Olabanji 2013; Majekodunmi 
& Odeku 2009). Up till now, the design and formulation 
of herbal tablet is still very challenging task due to poor 
tableting properties of the herbs and their dried extract 
(Chaves et al. 2009; Ghiware Nitin B. 2010). There are 
still very few researchers applying the technique of design 
of experiments (DOE) in developing direct compressed 
herbal tablet and most of these researches are done in India 
(Ganapaty et al. 2013; Ramaiah et al. 2013; Savarikar et 
al. 2011). 
 In this research, Diabecine™ was selected as the 
traditional antidiabetic formulation to be transformed from 
raw powder in hand filling capsule form into herbal tablets 
via direct compression. This particular formulation has 
been prescribed by an Indonesian traditional practitioner 
to diabetic patients in the form of hand filling capsules 
for more than 50 years. Until this study, Diabecine™ is 
a homemade product from a few types of herbs with no 
scientific evidence and R&D to improve its appearance and 
standardize its dosage. The produced tablets were studied 
for their tablet characteristics (weight, hardness, friability 
and disintegration time) and drug-excipient compatibility 
to ensure they comply with the pharmacopoeia standard. 
The tablets were also been tested on their safeness via 
heavy metals and microbiological analysis based on the 
requirements of NPCB, Malaysia.
MATERIALS AND METHODS
The herbal formulation that was developing into 
antidiabetic tablet in this research was supplied by a 
traditional herbal medicine producer Millenium Multiherbs, 
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Johor. It contains several medicinal plants powders such 
as Indonesian bay leaves (Syzygium polyantum), king of 
bitters (Andrographis paniculata), Java tea (Orthosiphon 
stamenius), Ceylon cinnamon (Cinnamon verum) and 
Javanese tumeric (Curcuma xanthorrhizae). The herbs 
were grinded and passed through a 200 μm sieve, those 
powders retained in the sieve were collected, regrind and 
sieve again. The powders were than mixed well and keep 
at cold, dried place for further use.
DESIGNING OF DIRECT COMPRESSED TABLET
The designs of experiments were done by Design-Expert® 
software. Formulations were developed following the 
D-optimal mixture design which is a design that is 
flexible enough to accommodate design constraints and 
model changes. The coordinate of 17 design points for 
the constrained were generated and randomly arranged by 
Design-Expert®. Three constituents were mixed according 
to the design with multiple constraints on the component 
proportions as stated in Tables 1 and 2. The mixtures of 
powders were then kept in air-tight container and labeled. 
Direct compressions of tablets were carried out by rotary 
tableting machines located in Institute of Bioproduct 
Development, Universiti Teknologi Malaysia. 
TABLET CHARACTERISTIC
The characteristic of tablets were determined by test 
apparatuses located at Faculty of Pharmacy, Universiti 
Kebangsaan Malaysia.
WEIGHT MEASUREMENTS
The weights of tablets were measured using tablet 
weighting tool (Sartorius) by weighting 20 tablets 
individually and calculate the average of weight for 
the samples. Comparison was then made between the 
individual tablet weights and the average weight. The 
amount of tablets differs from the average weight must be 
less than two tablets and should not exceed the percentage 
as listed in Table 3. No tablet must differ by more than 
double the relevant percentage.
HARDNESS, DIAMETER AND THICKNESS MEASUREMENTS
Tablet crushing strength (hardness), tablets diameter and 
thickness was checked by carried out hardness measurement 
by using 3 in 1 hardness tester (Model PTB311E, Pharma-
test) where a random samples of (ten tablets) was taken 
and allow to age for 24 h after production. The samples 
were tested individually using automate 3 in 1 tablet testing 
instrument and each value reported is a calculated average 
of ten measurements. Normally oral tablets should have 
hardness from 4-10 kg while some sustained release tablets 
are 10-20 kg which is much harder.
FRIABILITY
The friability of tablets was measured by Roche Friabilator 
(Copley) where 20 tablets were chosen randomly and 
weighed. The tablets were then placed in the friabilator and 
exposed to rolling and continual shocks as they fall 6 inches 
in each turn within the friabilator. After 100 revolutions, 
the final weights of tablets were taken. Comparison was 
made between the reading of initial and final weight. Tablet 
friability is the loss due to abrasion and it will be expressed 
as a percentage. Any cracked tablets were excluded from 
the calculation and the maximum acceptable weight loss 
is less than 1% of the weight of tablets being test (Odeku 
2008).
DISINTEGRATION TIME
Disintegration times of developed tablets were determined 
by using tablet disintegration test apparatus (Copley 
Scientific). For uncoated tablet, the disintegration time 
was tested by placing one tablet in each of the tubes of the 
basket and adds a disk to each tube on top of the tablet. 
Operate the apparatus, using water or the specified medium 
as the immersion fluid, maintained at 37 ± 2oC. At the end 
of 15 min, lift the basket from the fluid and observe the 
tablets: All of the tablets disintegrate completely. If 1 or 2 
tablets fail to disintegrate completely, repeat the test on 12 
additional tablets. The requirement is met if not less than 
16 of the total of 18 tablets tested disintegrate completely 
(Davydova 2008).
HEAVY METALS AND MICROBIOLOGICAL ANALYSIS OF 
DEVELOPED TABLETS
After the analysis of tablet characteristic, the tablet 
formulation with best performance was selected and 
subjected for element testing to test the availability of 
inorganic element content such as cadmium, mercury, 
arsenic and lead. It was also subjected for microbiological 
testing to assess the safety of raw materials. The 
microbiological testing include testing the existence of 
TABLE 1. Variables and intervals selected to perform the mixture design
Variables
Level
Low High
A=fraction of Diabecine™
B=fraction of MCC
C=Fraction of Aerosil
30
45
0
55
70
1
The amount of total mixture, A+B+C=100%
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Escherichia coli, Salmonella, Staphylococcus aureus, 
Enterobacteriaceae and certain other gram negative 
bacteria, total plate count and total yeast and mould count. 
These independent tests were conducted by Chemical 
Laboratory (Malaysia) Sdn. Bhd. by referring to the British 
Pharmacopoiea (2004). The samples are required to pass 
these tests in order to fulfill the requirement of NPCB, 
Malaysia as a registrable traditional medicine. 
HERBS-EXCIPIENT COMPATIBILITY STUDY
The Diabecine™ polyherb powder, powdered F5 tablet, 
Aerosil, microcrystalline cellulose and the mixture 
of excipients (Aerosil with MCC) were subjected to 
IR spectroscopic study using FT-IR spectrophotometer 
(Spectrum One, Perkin-Elmer) in Universiti Teknologi 
Malaysia by employing standard KBr pellet technique. 
The sample powder was grind with potassium bromide 
(KBr) in the ration of 1:100 (2 mg of sample in 200 mg 
of KBr). The mixture was then being placed in the mold 
and pressed to form the thin pellet (approximately 1 mm 
in thickness and 5 mm in diameter. The mold and pellet 
was then placed in the FTIR machine and read for the 
spectra. The spectra were scanned over the wave number 
range from 4000 - 370 cm-1 in order to determine the 
herbs-excipients compatibility. FTIR spectrums were read 
as percent transmission (% T).
RESULTS AND DISCUSSION
ASSESSMENT OF THE MECHANICAL 
STRENGTH OF TABLETS
According to U.S. Pharmacopeia, the mechanical strength 
of tablets is of considerable importance and is routinely 
measured as a guideline for product development and as 
a quality control requirement. Tablets cannot be too hard 
in view of the fact that it may affect the disintegration or 
drug release profile (Kim 2009). While the measurement 
of the tablets’ breaking force (commonly called hardness) 
provides some indication of the tablets’ mechanical 
robustness, it does not accurately measure the ability of 
the tablets to withstand the handling they will come across 
during processing and shipping. Therefore, a friability test 
is designed to determine the weakness of tablets and assess 
the resistance of the tablet surface regions to abrasions or 
other forms of general damages (<1217>2009), (Banker et 
al. 2002). These two tests are usually employed to measure 
the mechanical strength of a tablet.
 Table 4 shows the hardness, thickness and diameter of 
tablets for each formulation. Values are expressed in mean 
± SD, n=20. The thicknesses of the tablets ranged from 
4.94 ± 0.06 to 5.26 ± 0.02 mm and diameter from 9.56 ± 
0.03 to 9.64 ± 0.02 mm. The tablet hardness of different 
formulations ranged from 25.3 ± 1.1 N to 148.9 ± 14.9 N. 
A normal tablet should have a hardness value ranged from 
40 to 100 N. Thus, the tablets of F2, F4, F10, F13, F15 and 
F16 were failed in the hardness test because their hardness 
value is out of the acceptable range. 
 The tablet friability was determined according to 
procedure provided in U.S. Pharmacopeia using a friability 
tester. One percent of weight loss is considered as the 
maximum acceptable mean weight loss for the samples. 
TABLE 2. DOE parameter proportion (%) in the mixture
Run A:Diabecine™ B:MCC C:Aerosil
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
53.572
50.274
33.014
53.572
40.346
43.440
37.938
47.099
30.000
54.705
47.099
35.061
54.705
30.000
30.000
30.000
42.252
45.428
49.123
66.986
45.428
59.105
55.565
62.062
52.901
70.000
45.000
52.901
63.939
45.000
70.000
69.003
69.003
57.252
1.000
0.603
0.000
1.000
0.549
0.995
0.000
0.000
0.000
0.295
0.000
1.000
0.295
0.000
0.997
0.997
0.497
Each run composition was random and arranged according to mixture design D-optimal model provided by the Design 
Expert ® software
TABLE 3. Weight variation requirement
Average weight Percent difference
130 mg or less
More than 130 mg through 324 mg
More than 324 mg
10
7.5
5
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Table 4 indicates that all samples pass the friability test with 
less than 1% weight loss. Weight loss of all 17 formulations 
ranged from 0.087 to 0.823%. The sample with greatest 
weight loss was sample F13, with 0.823% of weight loss. 
Although it meets the friability standard of less than 1% 
weight loss, this formulation has the least crushing strength 
(25.3 ± 1.1 N) and it is most friable and hence is not ideal 
as tablets. 
 Crushing strength-friability ratio (CSFR) is an index of 
measuring tablet quality by comparing the measurement 
of tablet strength (hardness) and weakness (friability). It 
was calculated by dividing the crushing strength by the 
friability. The effect of formulation changes on the tablet 
mechanical strength can be evaluated by referring to the 
CSFR value of the tablets. Generally, the higher the CSFR 
value, the stronger the tablet is (Adetunji et al. 2006; 
Gbenga & Olabanji 2013; Majekodunmi & Odeku 2009). 
The CSFR for the 17 formulations ranged from 31.46 to 
1556.114. Basically, when the proportion of MCC increased, 
the hardness of the tablets increased and as a result, CSFR 
also increased. As shown in Table 4, of all the formulations, 
F16 showed the highest CSFR while F13 had the lowest. By 
referring to the measured hardness, friability and CSFR, we 
can conclude that tablets made from F13 were the weakest 
among all because it has the lowest CSFR ratio, highest 
weight loss in friability test and lowest hardness value.
 The disintegration test was carried out to determine the 
time required for a tablet to completely disintegrate when 
immersed in a certain test fluid. The maximum allowed 
disintegration time for an uncoated tablet is 15 min (2006). 
The disintegration of a tablet in the gastrointestinal tract 
is a crucial step in absorption and bioavailability through 
the epithelial membranes (Ibezim et al. 2008). Generally, 
fast disintegrating tablets do not necessarily guarantee 
fast bioavailability but slow disintegrating tablets almost 
assure slow bioavailability for all the time (Carter 2006). 
The tablet must disintegrate into its primary particles 
as quickly as possible to achieve optimal dissolution of 
active constituent and result in higher bioavailability 
(Gibson 2001). In this experiment, all tablets disintegrated 
completely within the standard time limit of 15 min 
and passed the disintegration test. The short periods of 
disintegration time are possibly due to the presence of 
large amounts of disintegrant (microcrystalline cellulose). 
The average weight of tablets for the difference formulations 
ranged from 0.332 ± 0.003 to 0.377 ± 0.009 g. The 
average content of Diabecine™ polyherb was calculated 
by multiplying the mean weight of produced tablet with 
the percentage of Diabecine™ powder (AI) in the same 
formulation. Thus the average content of AI in one tablet for 
the different formulations ranged from 111 ± 0.002 to 190 
± 0.004 g. From Table 5, it shows that all samples passed 
the weight variation test except sample F7 and F12. Both 
sample F7 and F12 have more than 50% of MCC. MCC is 
an excipient that functions as a glidant, disintegrant and 
binder with good flow properties, therefore there is a high 
possibility they failed the test due to human error or errors 
occurred during the mixing or tableting process for these 
particular formulations. 
 Among the formulations that passed all the physical 
quality examinations as discussed previously, tablet of 
F5 and F14 possess the highest CSFR values, which is 
1065.46 and 635.61, respectively. Although tablets of 
F14 have a lower weight lost percent in friability test 
and higher hardness value if compared to tablets of F5, 
but F14 contained less amount of Diabecine™ (30%) 
TABLE 4. Hardness, thickness, diameter, friability and CSFR of tablets
Batch
Hardness, N
(Mean±SD),
n=20
Thickness, mm
(Mean±SD), 
n=20
Diameter, mm
(Mean±SD), 
n=20
Friability, 
%
CSFR
Disintegration 
time (s)
F1
F2
F3
F4
F5
F6
F7
F8
F9
F10
F11
F12
F13
F14
F15
F16
F17
54.6 ± 6.7
37.7 ± 1.9
54.2 ± 2.9
39.4 ± 4.2
86.3 ± 8.1
55.9 ± 3.5
76.8 ± 12.0
42.3 ± 1.6
88.5 ± 10.9
33.3 ± 3.3
43.0 ± 2.9
110.8 ± 4.7
25.3 ± 1.1
92.6 ± 9.2
134.2 ± 13.6
148.9 ± 14.9
52.5 ± 3.6
5.19 ± 0.05
5.26 ± 0.02
5.13 ± 0.02
5.19 ± 0.03
5.19 ± 0.04
5.20 ± 0.02
4.94 ± 0.06
5.04 ± 0.03
5.18 ± 0.04
5.05 ± 0.02
5.12 ± 0.03
5.24 ± 0.03
5.21 ± 0.01
5.12 ± 0.05
5.16 ± 0.06
5.17 ± 0.07
5.20 ± 0.03
9.61 ± 0.01
9.63 ± 0.03
9.59 ± 0.01
9.62 ± 0.02
9.58 ± 0.01
9.61 ± 0.01
9.57 ± 0.01
9.58 ± 0.01
9.57 ± 0.01
9.61 ± 0.01
9.62 ± 0.01
9.57 ± 0.02
9.64 ± 0.02
9.56 ± 0.03
9.57 ± 0.02
9.57 ± 0.02
9.62 ± 0.03
0.184
0.322
0.211
0.241
0.136
0.313
0.240
0.282
0.188
0.335
0.409
0.127
0.823
0.087
0.122
0.096
0.261
296.96
117.00
256.44
163.12
635.61
178.76
320.15
150.27
470.97
99.40
105.07
870.68
31.46
1065.46
1098.77
1556.11
201.55
40
22
38
26
56
31
42
29
46
17
24
60
10
88
85
90
35
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in the formulation. Thus, tablets of F5, with 40.35% of 
Diabecine™ in the formulation, were selected as the 
best performed tablets. Quality control tests and safety 
monitoring of herbal products are crucial to ensure the 
patients can ingest herbal medicines safely. Unregulated 
products and ineffective quality control may lead to serious 
public health concerns. F5 tablets were later subjected to 
further safety evaluation based on the requirements of 
NPCB, Malaysia. 
SAFETY ASSESSMENT OF SELECTED (F5) TABLET
HEAVY METAL ANALYSIS
Herbal products are created from natural resources such as 
plants and therefore may contain heavy metals absorbed 
from fertilizers, pesticides and polluted water or soil during 
growth (Yuan et al. 2009). Heavy metals such as mercury, 
arsenic, cadmium and lead are toxic to humans. For this 
reason, it is essential to determine the quality of herbal 
products by carrying out a heavy metal analysis. 
 The Independent heavy metal limit tests on F5 tablet 
were carried out by Chemical Laboratory (Malaysia) Sdn. 
Bhd. As shown in Table 6, all tested metallic elements were 
not detected in the samples. The acceptance criteria of heavy 
metal limit test were set by referring to Drug Registration 
Guidance document by National Pharmaceutical Control 
Bureau, Malaysia (2013). Therefore, in respect to heavy 
metals, F5 tablets are safe for consumption. The results of 
heavy metal limit test were shown in Table 6. There was 
no detection of lead, arsenic, mercury and cadmium in the 
samples. 
MICROBIOLOGICAL ANALYSIS ON F5 TABLETS
Herbal plants may be contaminated with ‘invisible’ 
bacteria, fungi and viruses due to naturally occurrence or 
poor handling and can cause toxicity to the final products 
(Bandaranayake 2006). Independent microbial analyses 
were carried out to investigate the existence of microbial 
contamination. The results in Table 7 shows that all the 
tested results were within acceptable criteria according 
to the British Pharmacopeia 2013, Appendix XVI and 
Drug Registration Guidance Document by National 
Pharmaceutical Control Bureau of Malaysia. There were 
insignificant amounts of aerobic microbes detected in the 
total plate count while the other tested microbes were 
absent in F5 tablets. 
 Herbs-excipients Compatibility Study and Functional 
Groups Identification Drug-excipient compatibility plays a 
key role in the release of drug thus it is necessary to check 
the drug compatibility with the excipient while developing 
a new formulation. While most of the excipients are 
TABLE 5. Weight variation of tablets
Formulation
Weight, g
(Mean ±SD), n=20
Average amount of API per tablet, 
mg
(Mean ±SD), n=20
Verdict
F1
F2
F3
F4
F5
F6
F7
F8
F9
F10
F11
F12
F13
F14
F15
F16
F17
0.355 ± 0.008
0.352 ± 0.003 
0.348 ± 0.004
0.340 ± 0.004
0.375 ± 0.009 
0.352 ± 0.004
0.346 ± 0.012 
0.341 ± 0.004 
0.373 ± 0.007
0.332 ± 0.003
0.341 ± 0.008
0.368 ± 0.022
0.335 ± 0.004
0.371 ± 0.006
0.377 ± 0.009
0.377 ± 0.008
0.353 ± 0.004
190 ± 0.004
177 ± 0.001
115 ± 0.001
182 ± 0.002
151 ± 0.003
153 ± 0.002
131 ± 0.005
160 ± 0.002
112 ± 0.002
182 ± 0.002
161 ± 0.004
129 ± 0.008
183 ± 0.002
111 ± 0.002
113 ± 0.003
113 ± 0.002
149 ± 0.002
passed
passed
passed
passed
passed
passed
failed
passed
passed
passed
passed
failed
passed
passed
passed
passed
passed
TABLE 6. The content of heavy metals in a F5 tablets
Parameters Methods Acceptance criteria Results
Lead, Pb
Arsenic, As
Mercury, Hg
Cadmium, Cd
Acid Digestion/ AAS
Hydride Generation / AAS
Hydride Generation / AAS
Acid Digestion/ AAS
NMT 10.0 ppm
NMT 5.0 ppm
NMT 0.5 ppm
NMT 0.3 ppm
Not detected 
Not detected 
Not detected
Not detected
NMT: Not More Than 
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considered inert, there are some specific excipients 
that are incompatible with certain materials (Rowe et 
al. 2009). Excipient-drug interaction and poor quality 
excipients may contribute to the instability of the active 
substance or other quality issues. 
 In recent years, FTIR (Fourier Transform Infrared) 
spectroscopy has made a remarkable role in the field 
of medicinal plant analysis. It is used as a rapid quality 
control for herbs and is able to detect any changes in the 
physical and chemical constitution of drug-excipient 
mixtures. In this case, the pure drug and physical mixture 
of drug and excipient were subjected to FTIR detection. 
The IR spectra of the drug before and after combining with 
excipient were compared and observed changes in the 
main peaks. If there were no changes in the main peaks 
for the spectra of drug and drug-excipient, it means there 
was no interaction between the drug and excipient (Chen 
et al. 2010; Deepak et al. 2011; Gilhotra et al. 2013; Jain 
et al. 2010). 
 Usually, commercial IR spectrometer covers 4000-
400 cm-1 (Nair et al. 2013). A frequency region of 4000-
1300 cm-1 is the region for functional groups while 1300 
cm-1 and below are the fingerprint region (Ning 2011). 
Absorption occurs when the IR radiant energy matched 
to the energy of specific molecular vibration. As a result, 
the spectrum of each sample is unique, as no different 
molecular structure can produce the same spectra (Joshi 
2012). 
 In this study, the F5 excipient mixture (which contain 
0.55% of Aerosil and 59.10% of MCC according to the 
formulation in F5 tablet), Diabecine™ raw polyherb and 
F5 tablets were both examined via FTIR to identify the drug-
excipient compatibility and the existence of functional 
groups in the formulation. From the spectra recorded, 
the main peaks’ values in both Diabecine™ and F5 tablet 
(Figure 1) were found to be very similar. This means that 
there are no chemical interactions or physical changes 
between the active ingredient and excipients used. 
 This study has proven that direct compression of 
tablets containing high dosages of polyherbal powder is 
achievable. On top of that, DiabecineTM tablets have passed 
all of the pharmaceutical tests conducted and therefore have 
proven their good physical properties and safety. However, 
due to limitations of resources and time, bioavailability 
tests of the DiabecineTM tablets were not carried out. Also, 
although DiabecineTM tablets have passed the disintegration 
test, their disintegration time is quite short. Therefore, the 
authors suggested coating these tablets in order to prolong 
the disintegration time and improve the appearances of 
these tablets. 
TABLE 7. Microbiological quality of F5 tablet
Parameters test Methods Acceptance Criteria Results
Total plate count, cfu/g
E. Coli in 1 g
Salmonella in 10 g
Staphylococcus aureus in 1 g
Enterobacteriaceae and certain other gram negative bacteria
BP 2004
BP 2004
BP 2004
BP 2004
BP 2004
NMT 2×105 CFU 
NMT 2×102 CFU 
NMT 2×103 CFU 
Absence 
Absence 
7.2 × 102
Absent 
Absent 
Absent 
Absent
NMT: Not More Than; BP: British Pharmacopeia
Total Plate Count: Total Aerobic Microbial Count
FIGURE 1. FTIR Spectrum for MCC, Aerosil, F5 excipient mixture, raw Diabecine™ polyherb powder and F5 tablet
  603
CONCLUSION
This study was intended to convert a traditional 
polyherbal formulation, Diabecine™, from hand-filing 
capsules into modern oral tablets via direct compression 
that complied with pharmacopoeia standards and the 
NPCB, Malaysia requirements. It was found that tablets 
with the formulation of 40.35% Diabecine™ polyherb 
powder, 59.10% MCC and 0.55% Aerosil performed best 
in all physical quality tests. These tablets were found 
to be free from heavy metals and complied with the 
microbiological criteria. The herbs were found to be 
compatible with the excipient. In conclusion, from all the 
physical evaluation data and safety evaluations, it was 
found that the tablet formulation of DiabecineTM showed 
satisfactory results and it is suitable to be manufactured 
by using direct compression method.
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